Gerhard Levy Endowment Fund

Two students examining a vial.

The Department of Pharmaceutical Sciences uses this fund to support scholarships for outstanding graduate students as well as the Levy Lecture.

Dr. Gerhard Levy is considered the father of pharmacodynamics for his role as a pioneer and principal contributor in the fields of biopharmaceutics, pharmacokinetics, clinical pharmacokinetics and pharmacodynamics.

This fund enables the Department of Pharmaceutical Sciences to provide for Levy Graduate Scholarships as well as the Gerhard Levy Distinguished Lectureship. The fund was established in 1999 by various donors.

Dr. Levy was a UB faculty member from 1959 until he retired in 2000. Throughout his distinguished career, he served on several editorial boards, wrote many articles and received honorary doctorates from six universities.

Dr. Levy received numerous awards, including the first Lifetime Achievement in the Pharmaceutical Sciences Award from the International Pharmaceutical Federation; the Medeval Distinguished Lecturer in Pharmaceutical Sciences from the University of Manchester, England; and the Distinguished Investigator Award from the American College of Clinical Pharmacology.

Make a Difference Now

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • Meaney named a 2023 Outstanding Reviewer for ACCP’s Pharmacotherapy Journal
    10/6/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a 2023 Outstanding Reviewer for the American College of Clinical Pharmacy’s (ACCP) Pharmacotherapy Journal.
  • Katche appointed clinical assistant professor in the Division of Outcomes and Practice Advancement
    5/19/23
    Christ Ange (Angel) Katche, PharmD ’19, MBA ’19, BCACP, will join University at Buffalo School of Pharmacy and Pharmaceutical Sciences (SPPS) faculty in July as a clinical assistant professor in the Division of Outcomes and Practice Advancement, Department of Pharmacy Practice. In this role, her primary responsibility will be to coordinate and teach topics in ambulatory care and business, engage in community and global health initiatives, and maintain an experiential training site and research program in ambulatory care pharmacy practice.
  • Bies appointed associate dean for Graduate Education
    9/20/23
    Robert Bies, PharmD, PhD, professor, Department of Pharmaceutical Sciences, has been appointed associate dean for Graduate Education, effective September 1.
  • Jacobs receives UB Exceptional Scholar Young Investigator Award
    7/18/23
    David Jacobs, PharmD, PhD, assistant professor, Department of Pharmacy Practice, has received a 2023 Exceptional Scholar Young Investigator Award from the University at Buffalo (UB).
  • UB SPPS hosts Ann E. Weber, PhD, as 2023 David Chu lecturer
    5/9/23
    On May 8, the University of Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) welcomed Ann E. Weber, PhD, senior vice president, Research and Development, Kallyope Inc., as our 2023 David Chu Lecturer.
  • UB CIGBS Announces Stop Diabetes Progression, a New Global Community Health Site Initiative
    10/18/23
    The University at Buffalo (UB) Center for Integrated Global Biomedical Sciences (CIGBS) has announced plans to launch, Stop Diabetes Progression, a new health initiative, focusing on the creation of community-based education networks in Western New York, Jamaica and Zimbabwe to engage individuals with pre-diabetes and those with an established diagnosis of diabetes mellitus. The goal of this new initiative is to stop the progression of the disease for both groups.
  • UB Center for Integrated Global Biomedical Sciences receives NIH funding for Cloud-based Viral Surveillance Research Training Program in Jamaica
    8/9/23
    The Center for Integrated Global Biomedical Sciences at the University at Buffalo (UB), State University of New York (SUNY) has received funding to expand its Global Infectious Diseases (GID) Research Training Program. The GID is supported by the Fogarty International Center at the National Institutes of Health (NIH) for pre-doctoral and post-doctoral training that will lead to capacity building in Jamaica through UB/SUNY and the University of the West Indies (UWI) collaboration. Importantly, this new funding includes CTIS, a key cloud project implementation partner, and a women-owned small business with expertise in providing informatics solutions for clinical trials and research for over 30 years.